PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1402581
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1402581
The photomedicine market size is expected to reach US$ 7.6 billion by 2030, from US$ 3.6 Billion in 2023, at a CAGR of 11.3% during the forecast period.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 3.6 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 11.30% | 2030 Value Projection: | US$ 7.6 Bn |
Photomedicine is a branch of medicine that involves the use of light and photobiology for diagnosis and treatment. It has gained significant attention in recent years due to its non-invasive nature and the potential for targeted therapy. The field encompasses various applications, including photodynamic therapy, low-level laser therapy, and photobiomodulation. Photomedicine provides promising alternatives to traditional medical interventions, offering patients safer and more efficient treatment options. The technology has evolved significantly with advancements in laser and light-based devices, enhancing the efficacy and reliability of photomedicine procedures.
The photomedicine market is driven by several factors, including the growing demand for minimally invasive procedures, the increasing prevalence of skin disorders and chronic diseases, and the expanding geriatric population. For instance, on February 8, 2023, according to a report published by John Wiley & Sons, Inc., a multinational publishing company, about 20% of children and up to 10% of adults suffer with eczema, which is linked to a significant burden of morbidity and expenses for both individuals and healthcare systems.. The advancements in laser and light-based technologies have made photomedicine more accessible and effective, further driving market growth.
However, market growth may be hindered by factors such as the high cost of photomedicine devices and treatments, strict regulatory requirements, and a lack of skilled professionals. Moreover, the COVID-19 pandemic has affected the market negatively, leading to a decline in elective procedures due to lockdowns and safety restrictions.
Despite these challenges, there are several opportunities for market expansion. The rising adoption of telemedicine and the increasing focus on personalized medicine present avenues for the growth of photomedicine. Additionally, the development of portable and handheld devices, along with the integration of artificial intelligence and machine learning, opens up new possibilities for improved diagnosis and treatment within the field.